IMID.L vs. GXLV.L
IMID.L (SPDR MSCI ACWI IMI UCITS ETF) and GXLV.L (SPDR S&P US Health Care Select Sector UCITS ETF) are both exchange-traded funds - IMID.L is a Global Equities fund tracking the MSCI ACWI Investable Market Index, while GXLV.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD. Both are passively managed. Over the past 10 years, IMID.L returned -18.50%/yr vs 6.98%/yr for GXLV.L. At a 0.43 correlation, their price movements are largely independent. IMID.L charges 0.17%/yr vs 0.15%/yr for GXLV.L.
Performance
IMID.L vs. GXLV.L - Performance Comparison
Loading charts...
Different Trading Currencies
IMID.L is traded in USD, while GXLV.L is traded in GBP. To make them comparable, the GXLV.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, IMID.L achieves a -95.51% return, which is significantly lower than GXLV.L's 5.27% return. Over the past 10 years, IMID.L has underperformed GXLV.L with an annualized return of -18.50%, while GXLV.L has yielded a comparatively higher 6.98% annualized return.
IMID.L
- 1D
- 0.38%
- 1M
- 1.62%
- 6M
- -95.56%
- YTD
- -95.51%
- 1Y
- -95.00%
- 3Y*
- -58.96%
- 5Y*
- -41.77%
- 10Y*
- -18.50%
GXLV.L
- 1D
- 0.00%
- 1M
- 6.06%
- 6M
- 6.31%
- YTD
- 5.27%
- 1Y
- 22.18%
- 3Y*
- 9.44%
- 5Y*
- -0.46%
- 10Y*
- 6.98%
IMID.L vs. GXLV.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IMID.L SPDR MSCI ACWI IMI UCITS ETF | -95.51% | 22.16% | 16.31% | 21.65% | -17.64% | 17.85% | 16.14% | 25.35% | -9.83% | 22.56% |
GXLV.L SPDR S&P US Health Care Select Sector UCITS ETF | 5.27% | 15.16% | 2.00% | 1.16% | -27.54% | 24.44% | 16.42% | 25.10% | 0.01% | 32.96% |
Correlation
The correlation between IMID.L and GXLV.L is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.42 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since Jul 7, 2015 | 0.43 |
Over the past year, the correlation between IMID.L and GXLV.L has dropped to 0.19 - well below their long-term average of 0.43, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IMID.L vs. GXLV.L — Risk / Return Rank
IMID.L
GXLV.L
IMID.L vs. GXLV.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR MSCI ACWI IMI UCITS ETF (IMID.L) and SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IMID.L | GXLV.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.44 | ||
| Sortino ratioReturn per unit of downside risk | -3.03 | ||
| Omega ratioGain probability vs. loss probability | 0.55 | 1.26 | -0.70 |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | 2.13 | -3.12 |
| Martin ratioReturn relative to average drawdown | -1.49 | 5.18 | -6.66 |
Loading charts...
Drawdowns
IMID.L vs. GXLV.L - Drawdown Comparison
The maximum IMID.L drawdown since its inception was -96.27%, which is greater than GXLV.L's maximum drawdown of -37.17%. Use the drawdown chart below to compare losses from any high point for IMID.L and GXLV.L.
Loading charts...
Drawdown Indicators
| IMID.L | GXLV.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.27% | -37.17% | -59.10% |
Max Drawdown (1Y)Largest decline over 1 year | -96.27% | -10.45% | -85.82% |
Max Drawdown (3Y)Largest decline over 3 years | -96.27% | -17.58% | -78.69% |
Max Drawdown (5Y)Largest decline over 5 years | -96.27% | -37.17% | -59.10% |
Max Drawdown (10Y)Largest decline over 10 years | -96.27% | -37.17% | -59.10% |
Current DrawdownCurrent decline from peak | -95.62% | -9.51% | -86.11% |
Average DrawdownAverage peak-to-trough decline | -7.71% | -15.58% | +7.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 63.93% | 4.30% | +59.63% |
Volatility
IMID.L vs. GXLV.L - Volatility Comparison
The current volatility for SPDR MSCI ACWI IMI UCITS ETF (IMID.L) is 3.92%, while SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) has a volatility of 4.96%. This indicates that IMID.L experiences smaller price fluctuations and is considered to be less risky than GXLV.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IMID.L | GXLV.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.92% | 4.96% | -1.04% |
Volatility (6M)Calculated over the trailing 6-month period | 321.60% | 11.34% | +310.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 96.96% | 15.27% | +81.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.77% | 18.31% | +27.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.13% | 19.86% | +16.27% |
IMID.L vs. GXLV.L - Expense Ratio Comparison
IMID.L has a 0.17% expense ratio, which is higher than GXLV.L's 0.15% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
IMID.L vs. GXLV.L - Dividend Comparison
Neither IMID.L nor GXLV.L has paid dividends to shareholders.
Frequently Asked Questions
IMID.L and GXLV.L have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GXLV.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GXLV.L is cheaper with a 0.15% expense ratio, compared with 0.17% for IMID.L.
IMID.L is categorized as Global Equities, while GXLV.L is Health & Biotech Equities. IMID.L tracks MSCI ACWI Investable Market Index, while GXLV.L tracks MSCI World/Health Care NR USD. Their fees differ too: 0.17% for IMID.L and 0.15% for GXLV.L.
Find the right allocation for IMID.L and GXLV.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer